Tokyo, Japan

Keiko Ishioka


Average Co-Inventor Count = 7.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2003

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Keiko Ishioka: Innovator in Human Protein Research

Introduction

Keiko Ishioka, a prominent inventor based in Tokyo, Japan, has made significant contributions to the field of protein research. Known for her innovative approach, Ishioka holds a patent that addresses crucial aspects of immunology and hematology.

Latest Patents

Ishioka's notable patent is focused on the Human ADAMTS-1 protein, which includes a gene encoding the same and a pharmaceutical composition that utilizes this protein as an active ingredient. The patent outlines a method for immunologically analyzing the human ADAMTS-1 protein. This invention holds promise as it can decrease the number of leukocytes and platelets while simultaneously increasing the number of erythrocytes, providing valuable insights into potential therapeutic applications.

Career Highlights

Ishioka is affiliated with Kureha Chemical Industry Company, Limited, where she has applied her expertise in research and development. Her work has been pivotal in bridging the gap between fundamental science and practical applications in medicine. With her innovative mindset, she has become an influential figure in her field.

Collaborations

Throughout her career, Ishioka has worked alongside esteemed colleagues, including Kunitaka Hirose and Eiji Inoguchi. Their collaborative efforts have fostered an environment of innovation, leading to the advancement of knowledge and application in the field of protein research.

Conclusion

Keiko Ishioka's contributions to the understanding of human ADAMTS-1 protein exemplify the impact of dedicated inventors in the world of science and medicine. Her work not only enhances our understanding of cellular processes but also paves the way for potential therapeutic advancements. As innovators like Ishioka continue to push boundaries, the future of immunological research looks promising.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…